Fintel reports that on April 4, 2025, Redburn Atlantic downgraded their outlook for Qiagen N.V. (NYSE:QGEN) from Buy to ...

Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (NYSE:DGX) with a Buy ...

Redburn Atlantic downgraded Qiagen (QGEN) to Neutral from Buy with a price target of EUR 41, down from EUR 47. The firm reduced the company’s ...

Redburn Atlantic began coverage on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a report issued on Wednesday morning, MarketBeat reports. The firm issued a buy rating and a $195.00 price ...

Redburn Atlantic started coverage on shares of Laboratory Co. of America (NYSE:LH – Free Report) in a research note published on Wednesday, MarketBeat.com reports. The brokerage issued a buy rating ...

Redburn Atlantic initiated coverage of Labcorp (LH) with a Buy rating and $276 price target Don't Miss Our End of Quarter Offers: Discover the ...

Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Labcorp Holdings (BMV:LH) with a Buy recommendation. There are 3 funds or institutions reporting positions in Labcorp ...

Reddit has grown quickly since going public last year, but some analysts warn that its growth could be dependent on Google ...

Reddit Inc.’s stock has enjoyed significant gains since the social-media company’s initial public offering a year ago, buoyed ...

On Monday, Redburn-Atlantic revised its stance on QIAGEN NV (QIA:GR) (NYSE: QGEN), downgrading the company’s stock rating from Buy to Neutral and adjusting the price target from EUR47.00 to EUR41.00.

Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (LSE:0KSX) with a Buy recommendation. As of April 2, 2025, the average one-year price target for ...